{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Carcinome mucoépidermoïde : Questions médicales les plus fréquentes",
"headline": "Carcinome mucoépidermoïde : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Carcinome mucoépidermoïde : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-24",
"dateModified": "2024-12-21",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Carcinome mucoépidermoïde"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Tumeurs kystiques, mucineuses et séreuses",
"url": "https://recherchemedicale.com/mesh/D018297",
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs kystiques, mucineuses et séreuses",
"code": {
"@type": "MedicalCode",
"code": "D018297",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C04.557.470.590"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Carcinome mucoépidermoïde",
"alternateName": "Carcinoma, Mucoepidermoid",
"code": {
"@type": "MedicalCode",
"code": "D018277",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Cong-Cong Wu",
"url": "https://recherchemedicale.com/author/Cong-Cong%20Wu",
"affiliation": {
"@type": "Organization",
"name": "The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) & Key Laboratory of Oral Biomedicine Ministry of Education, School and Hospital of Stomatology, Wuhan University, Wuhan, China."
}
},
{
"@type": "Person",
"name": "Zhi-Jun Sun",
"url": "https://recherchemedicale.com/author/Zhi-Jun%20Sun",
"affiliation": {
"@type": "Organization",
"name": "The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) & Key Laboratory of Oral Biomedicine Ministry of Education, School and Hospital of Stomatology, Wuhan University, Wuhan, China."
}
},
{
"@type": "Person",
"name": "Alexandros Poutoglidis",
"url": "https://recherchemedicale.com/author/Alexandros%20Poutoglidis",
"affiliation": {
"@type": "Organization",
"name": "Department of Otorhinolaryngology-Head and Neck Surgery, George Papanikolaou General Hospital, Thessaloniki, GRC."
}
},
{
"@type": "Person",
"name": "Paraskevi Karamitsou",
"url": "https://recherchemedicale.com/author/Paraskevi%20Karamitsou",
"affiliation": {
"@type": "Organization",
"name": "Department of Otorhinolaryngology-Head and Neck Surgery, George Papanikolaou General Hospital, Thessaloniki, GRC."
}
},
{
"@type": "Person",
"name": "William Faquin",
"url": "https://recherchemedicale.com/author/William%20Faquin",
"affiliation": {
"@type": "Organization",
"name": "Massachussetts General Hospital, Boston, MA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Clinicopathological Features of Non-Small Cell Lung Carcinoma with BRAF Mutation.",
"datePublished": "2023-11-19",
"url": "https://recherchemedicale.com/article/37999148",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/curroncol30110728"
}
},
{
"@type": "ScholarlyArticle",
"name": "USP11 potentiates HGF/AKT signaling and drives metastasis in hepatocellular carcinoma.",
"datePublished": "2023-11-16",
"url": "https://recherchemedicale.com/article/37973952",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41388-023-02847-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "Nodal Metastasis in Surgically Treated Oral Cavity Squamous Cell Carcinoma.",
"datePublished": "2023-11-15",
"url": "https://recherchemedicale.com/article/37967536",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1159/000534491"
}
},
{
"@type": "ScholarlyArticle",
"name": "KIAA1429 facilitates progression of hepatocellular carcinoma by modulating m6A levels in HPN.",
"datePublished": "2023-11-08",
"url": "https://recherchemedicale.com/article/38058614",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.heliyon.2023.e22084"
}
},
{
"@type": "ScholarlyArticle",
"name": "Non-endoscopic Screening for Esophageal Squamous Cell Carcinoma: Recent Advances.",
"datePublished": "2023-11-04",
"url": "https://recherchemedicale.com/article/37924487",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12029-023-00980-x"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Recherchemedicale.com",
"item": "https://recherchemedicale.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Tumeurs",
"item": "https://recherchemedicale.com/mesh/D009369"
},
{
"@type": "ListItem",
"position": 3,
"name": "Tumeurs par type histologique",
"item": "https://recherchemedicale.com/mesh/D009370"
},
{
"@type": "ListItem",
"position": 4,
"name": "Tumeurs épithéliales épidermoïdes et glandulaires",
"item": "https://recherchemedicale.com/mesh/D009375"
},
{
"@type": "ListItem",
"position": 5,
"name": "Tumeurs kystiques, mucineuses et séreuses",
"item": "https://recherchemedicale.com/mesh/D018297"
},
{
"@type": "ListItem",
"position": 6,
"name": "Carcinome mucoépidermoïde",
"item": "https://recherchemedicale.com/mesh/D018277"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Carcinome mucoépidermoïde - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Carcinome mucoépidermoïde",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-02-02",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Carcinome mucoépidermoïde",
"description": "Comment diagnostique-t-on un carcinome mucoépidermoïde ?\nQuels examens d'imagerie sont utilisés ?\nQuels marqueurs tumoraux peuvent être recherchés ?\nLe diagnostic nécessite-t-il une endoscopie ?\nQuels symptômes peuvent alerter au diagnostic ?",
"url": "https://recherchemedicale.com/mesh/D018277?mesh_terms=Carcinoma,+Adenoid+Cystic&page=1000#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Carcinome mucoépidermoïde",
"description": "Quels sont les symptômes courants du carcinome mucoépidermoïde ?\nPeut-on avoir des symptômes respiratoires ?\nY a-t-il des signes de métastases ?\nLes changements de voix sont-ils possibles ?\nPeut-on avoir des saignements ?",
"url": "https://recherchemedicale.com/mesh/D018277?mesh_terms=Carcinoma,+Adenoid+Cystic&page=1000#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Carcinome mucoépidermoïde",
"description": "Peut-on prévenir le carcinome mucoépidermoïde ?\nLe dépistage est-il recommandé ?\nQuels facteurs de risque sont modifiables ?\nL'hygiène buccale joue-t-elle un rôle ?\nLes vaccinations peuvent-elles aider ?",
"url": "https://recherchemedicale.com/mesh/D018277?mesh_terms=Carcinoma,+Adenoid+Cystic&page=1000#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Carcinome mucoépidermoïde",
"description": "Quels sont les traitements standards ?\nLa radiothérapie est-elle toujours nécessaire ?\nQuand la chimiothérapie est-elle indiquée ?\nY a-t-il des traitements ciblés disponibles ?\nQuels soins de support sont recommandés ?",
"url": "https://recherchemedicale.com/mesh/D018277?mesh_terms=Carcinoma,+Adenoid+Cystic&page=1000#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Carcinome mucoépidermoïde",
"description": "Quelles sont les complications possibles ?\nLe carcinome peut-il entraîner des métastases ?\nQuels effets secondaires des traitements sont fréquents ?\nY a-t-il des risques de déformation après traitement ?\nComment gérer les complications ?",
"url": "https://recherchemedicale.com/mesh/D018277?mesh_terms=Carcinoma,+Adenoid+Cystic&page=1000#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Carcinome mucoépidermoïde",
"description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il le risque ?\nLes antécédents familiaux jouent-ils un rôle ?\nL'exposition professionnelle est-elle un facteur ?\nLe virus HPV est-il un facteur de risque ?",
"url": "https://recherchemedicale.com/mesh/D018277?mesh_terms=Carcinoma,+Adenoid+Cystic&page=1000#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on un carcinome mucoépidermoïde ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur une biopsie et l'examen histopathologique des tissus."
}
},
{
"@type": "Question",
"name": "Quels examens d'imagerie sont utilisés ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les examens comme l'IRM et le scanner sont utilisés pour évaluer l'extension tumorale."
}
},
{
"@type": "Question",
"name": "Quels marqueurs tumoraux peuvent être recherchés ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des marqueurs comme le CEA et le CA 19-9 peuvent être évalués, mais ne sont pas spécifiques."
}
},
{
"@type": "Question",
"name": "Le diagnostic nécessite-t-il une endoscopie ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une endoscopie peut être nécessaire pour visualiser les lésions dans certaines localisations."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent alerter au diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs, des masses palpables ou des difficultés à avaler peuvent alerter au diagnostic."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants du carcinome mucoépidermoïde ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des douleurs, des masses dans la bouche ou la gorge, et des difficultés à avaler."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes respiratoires ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes respiratoires comme la toux ou la dyspnée peuvent survenir si la tumeur est localisée dans les voies respiratoires."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes de métastases ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes de métastases peuvent inclure des douleurs osseuses ou des ganglions lymphatiques enflés."
}
},
{
"@type": "Question",
"name": "Les changements de voix sont-ils possibles ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des changements de voix peuvent survenir si la tumeur affecte les cordes vocales."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des saignements ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des saignements buccaux ou des saignements de nez peuvent se produire en cas d'ulcération tumorale."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir le carcinome mucoépidermoïde ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode de prévention spécifique, mais éviter le tabac et l'alcool peut aider."
}
},
{
"@type": "Question",
"name": "Le dépistage est-il recommandé ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le dépistage n'est pas systématique, mais des examens réguliers peuvent aider à détecter des anomalies."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque sont modifiables ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs de risque modifiables incluent le tabagisme, l'alcoolisme et l'exposition à des agents chimiques."
}
},
{
"@type": "Question",
"name": "L'hygiène buccale joue-t-elle un rôle ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une bonne hygiène buccale peut réduire le risque de cancers buccaux, y compris le carcinome mucoépidermoïde."
}
},
{
"@type": "Question",
"name": "Les vaccinations peuvent-elles aider ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vaccinations contre le HPV peuvent réduire le risque de certains cancers, mais pas spécifiquement du carcinome mucoépidermoïde."
}
},
{
"@type": "Question",
"name": "Quels sont les traitements standards ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la chirurgie, la radiothérapie et parfois la chimiothérapie."
}
},
{
"@type": "Question",
"name": "La radiothérapie est-elle toujours nécessaire ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La radiothérapie est souvent utilisée après la chirurgie pour réduire le risque de récidive."
}
},
{
"@type": "Question",
"name": "Quand la chimiothérapie est-elle indiquée ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chimiothérapie est indiquée pour les cas avancés ou métastatiques du carcinome mucoépidermoïde."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements ciblés disponibles ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements ciblés peuvent être envisagés dans le cadre d'essais cliniques pour certains patients."
}
},
{
"@type": "Question",
"name": "Quels soins de support sont recommandés ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des soins de support comme la gestion de la douleur et la nutrition sont essentiels pendant le traitement."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure des infections, des récidives et des effets secondaires des traitements."
}
},
{
"@type": "Question",
"name": "Le carcinome peut-il entraîner des métastases ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le carcinome mucoépidermoïde peut se propager à d'autres organes, entraînant des métastases."
}
},
{
"@type": "Question",
"name": "Quels effets secondaires des traitements sont fréquents ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires fréquents incluent la fatigue, les nausées et les problèmes buccaux."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de déformation après traitement ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des déformations faciales ou buccales peuvent survenir après une chirurgie ou une radiothérapie."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion des complications nécessite une approche multidisciplinaire incluant médecins et spécialistes."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux facteurs incluent le tabagisme, l'alcool, et l'exposition à des agents chimiques."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque augmente avec l'âge, les cas étant plus fréquents chez les adultes âgés."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de cancers peuvent augmenter le risque de carcinome mucoépidermoïde."
}
},
{
"@type": "Question",
"name": "L'exposition professionnelle est-elle un facteur ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines professions exposant à des produits chimiques peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Le virus HPV est-il un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le virus HPV est associé à certains cancers de la tête et du cou, y compris le carcinome mucoépidermoïde."
}
}
]
}
]
}
(1) Background: BRAF mutations affect 4-5% of lung adenocarcinomas. This study aimed to analyze the clinicopathological features of lung carcinomas with BRAF mutations, focusing on V600E vs. non-V600E...
USP11 is a member of the ubiquitin-specific protease family and plays a crucial role in tumor progression in various cancers. However, the precise mechanism by which USP11 promotes EMT and metastasis ...
Management of the neck in oral cavity squamous cell carcinoma (OCSCC) is essential to oncologic control and survival. The rates of lymph node metastasis (LNM) vary based on oral cavity tumor site and ...
We conducted a retrospective analysis of 25,846 surgically managed OCSCC patients from the National Cancer Database (NCDB) stratified by tumor subsite and clinical T-stage. For cN + patients, rates of...
A total of 25,846 patients (59.1% male, mean age 61.9 years) met inclusion criteria with primary tumor sites including oral tongue (50.8%), floor of mouth (21.2%), lower alveolus (7.6%), buccal mucosa...
Management of the neck in OCSCC should be tailored based on primary tumor factors and considered for early-stage tumors....
Most...
GEO and GEPIA2 databases were used to identify the m6A modification-related genes which were differentially expressed in LIHC and adjacent non-tumor tissues, and quantitative PCR was used to evaluate ...
KIAA1429 expression was markedly elevated in LIHC tissues, and patients with LIHC who had high KIAA1429 expression had a worse prognosis than those who had low expression. KIAA1429 silencing attenuate...
Our study suggests a KIAA1429-HPN modulatory model based on m6A modifications, that offers insights into the occurrence and development of LIHC....
Esophageal squamous cell carcinoma (ESCC) is one of the most common tumors in the gastrointestinal tract, and China has a high incidence area with a high burden on the disease. As early symptoms of ES...
Screening methods are divided into endoscopic and non-endoscopic screening....
Endoscopic screening cannot be widely used because of its invasive nature and high cost. Currently, non-endoscopic screening consists primarily of tumor biomarkers and cytology, and tumor biomarkers i...
Non-endoscopic screening is better than endoscopic screening. And the application of tumor biomarkers is much better than other non-endoscopic screening methods....
Hepatocellular carcinoma (HCC) is the most prevalent form of primary liver cancer. According to the American Cancer Society, among patients diagnosed with advanced liver cancer, HCC has the sixth-high...
Mitogen-activated protein kinases (MAPK), specifically the c-Jun N-terminal kinase (JNK)-MAPK subfamily, play a crucial role in the development of various cancers, including hepatocellular carcinoma (...
In this study, we performed differential expression analysis of JNK-MAPK components at both the transcriptome and protein levels using TCGA and HPA databases. We utilized Kaplan-Meier survival plots a...
JNK1/2 and MKK7 levels were significantly upregulated in HCC samples compared to paracarcinoma tissues, whereas MKK4 was downregulated. ROC analyses suggested that JNK2 and MKK7 may serve as suitable ...
Targeting MKK7, rather than JNK1/2 or MKK4, may be a promising therapeutic strategy to inhibit the JNK-MAPK pathway in HCC therapy....
The scientific world has recently shown wider attention to elucidating the anticancerous potential of numerous plant-based bioactive compounds. Many research studies have suggested that consuming food...
Hepatocellular carcinoma (HCC) mortality rates are increasing globally, and particularly in the Western world. Cirrhosis remains the predominant risk factor for HCC. However, epidemiological shifts in...